<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1650984</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>LncRNA NRIR inhibits osteogenesis by promoting macrophage M1 polarization through RSAD2/NF-&#x3ba;B axis in peri-implantitis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Renshengjie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3107444/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Lan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Keming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Qiqi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yu</surname>
<given-names>Ke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3020843/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The Affiliated Stomatological Hospital, Southwest Medical University</institution>, <addr-line>Luzhou</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Oral &amp; Maxillofacial Reconstruction and Regeneration of Luzhou Key Laborator</institution>, <addr-line>Luzhou</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Stomatology, Southwest Medical University</institution>, <addr-line>Luzhou</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/722359/overview">Stefania Fiorcari</ext-link>, Azienda Ospedaliero Universitaria di Modena, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/725818/overview">Prapansak Srisapoome</ext-link>, Kasetsart University, Thailand</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1014711/overview">Liangwen Chen</ext-link>, Wuhan University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2939491/overview">Adili Alimujiang</ext-link>, Jinan University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Ke Yu, <email xlink:href="mailto:yuke@swmu.edu.cn">yuke@swmu.edu.cn</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1650984</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Zhao, Wang, Zhou, Xiao, Liu and Yu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Zhao, Wang, Zhou, Xiao, Liu and Yu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Peri-implantitis is an inflammatory condition affecting the hard and soft tissues surrounding osseointegrated implants, characterized by progressive alveolar bone destruction. The long non-coding RNA Negative Regulator of Interferon Response (lncRNA <italic>NRIR</italic>) is widely recognized as a biomarker for certain autoimmune diseases and participates in their pathogenesis. However, our previous studies revealed significant upregulation of <italic>NRIR</italic> in peri-implantitis, suggesting its potential role in peri-implantitis. In peri-implantitis lesions, there is often a substantial infiltration of M1 macrophages. Thus, this study investigated the regulatory role and underlying mechanisms of <italic>NRIR</italic> in macrophage polarization during peri-implantitis.</p>
</sec>
<sec>
<title>Methods</title>
<p>Transcriptome sequencing analysis revealed radical S-adenosyl methionine domain containing 2 (<italic>RSAD2</italic>) as an <italic>NRIR</italic>-interacting mRNA in macrophages. Using siRNA gene knockdown technology, we suppressed <italic>NRIR</italic> and <italic>RSAD2</italic> expression in M1 macrophages derived from THP-1 cells. Subsequently, we employed RT-qPCR, Western blot, flow cytometry, and immunofluorescence staining to assess the levels of inflammatory cytokines and M1 macrophage-associated markers, aiming to elucidate the involvement of <italic>NRIR</italic>/<italic>RSAD2</italic>/NF-&#x3ba;B axis in macrophage polarization. Supernatants from <italic>NRIR</italic>-knockdown macrophages were collected to prepare the culture medium for bone marrow mesenchymal stem cells (BMSCs). The expression of osteogenic-related factors in BMSCs was evaluated through RT-qPCR, Western blot, Alkaline phosphatase (ALP) activity, and alizarin red S (ARS) staining. Furthermore, a rat peri-implantitis model was established, and the degree of peri-implant tissue inflammation and bone loss was assessed using micro-CT scanning and immunohistochemistry after treatment with various macrophage supernatants.</p>
</sec>
<sec>
<title>Results</title>
<p>
<italic>NRIR</italic> knockdown reduced <italic>RSAD2</italic> expression and suppressed activation of the NF-&#x3ba;B pathway, consequently decreasing inflammatory cytokines and M1 macrophage-associated cytokine expression in THP-1 macrophages. Functionally, <italic>NRIR</italic> knockdown in macrophages promoted osteogenic differentiation of BMSCs. In vivo experiments showed that supernatants derived from <italic>NRIR</italic>-knockdown macrophages resulted in reduced inflammatory infiltration, diminished bone resorption, and increased expression of osteogenesis-related factors.</p>
</sec>
<sec>
<title>Discussion</title>
<p>This study demonstrates that <italic>NRIR</italic> functions as a pro-inflammatory modulator in peri-implantitis by activating M1 macrophages through the <italic>RSAD2</italic>/NF-&#x3ba;B axis, providing novel insights into peri-implantitis pathogenesis that may inform future preventive and therapeutic strategies.</p>
</sec>
</abstract>
<kwd-group>
<kwd>LncRNA <italic>NRIR</italic>
</kwd>
<kwd>macrophage polarization</kwd>
<kwd>peri-implantitis</kwd>
<kwd>osteogenic differentiation</kwd>
<kwd>NF-&#x3ba;B</kwd>
<kwd>
<italic>RSAD2</italic>
</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="64"/>
<page-count count="13"/>
<word-count count="5404"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Inflammation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Peri-implantitis is a severe biological complication resulting from bacterial biofilm accumulation in peri-implant tissues, causing inflammation of peri-implant mucosa and subsequent progressive bone loss (<xref ref-type="bibr" rid="B1">1</xref>). Over the last 30&#x2009;years, peri-implantitis has emerged as a significant clinical concern in dentistry (<xref ref-type="bibr" rid="B2">2</xref>). Research in osteoimmunology indicates that continuous crosstalk between cells of the monocyte/macrophage/osteoclast lineage and the mesenchymal stem cell-osteoblast lineage determines whether a durable prosthesis-implant interface is established or implant loosening occurs (<xref ref-type="bibr" rid="B3">3</xref>). Therefore, exploring interactions between macrophages and mesenchymal stem cells can elucidate the pathogenesis of peri-implantitis.</p>
<p>Macrophages undergo polarization in response to environmental stimuli, with M1 macrophages critically involved in the development of bacterial-induced inflammation, while M2 macrophages contribute to inflammation resolution and tissue repair (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). A large population of M1 macrophages accumulates at sites of bone destruction in chronic osteolytic conditions such as arthritis and periodontitis (<xref ref-type="bibr" rid="B6">6</xref>). These macrophages produce substantial amounts of pro-inflammatory cytokines (TNF-&#x3b1;, IL-1, IL-12, IFN-&#x3b3;), chemokines, and matrix metalloproteinases, inducing osteoclastogenesis, tissue erosion, and progressive bone destruction (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). Studies have shown a significant correlation between increased M1 macrophage expression and deeper periodontal probing depths (<xref ref-type="bibr" rid="B11">11</xref>). Notably, samples from peri-implantitis lesions exhibit markedly increased M1 macrophage populations (<xref ref-type="bibr" rid="B12">12</xref>). This phenomenon likely contributes significantly to the destructive inflammatory response and severe peri-implant osteolysis characteristic of advanced peri-implantitis stages.</p>
<p>In recent years, long non-coding RNAs (lncRNAs) have attracted considerable scientific interest due to their abundance and potential regulatory roles in cellular, molecular, and pathophysiological processes. LncRNAs interact with DNA, RNA, or proteins, thereby regulating transcriptional, post-transcriptional, and translational outcomes (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Studies on lncRNA functions have suggested their potential as diagnostic/prognostic biomarkers and therapeutic targets in inflammatory diseases, including peri-implantitis and periodontitis (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). LncRNA Negative Regulator of Interferon Response (<italic>NRIR</italic>), an interferon-stimulated gene, is widely considered to play an essential role in the pathogenesis of autoimmune skin diseases, such as systemic sclerosis and systemic lupus erythematosus (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>). However, few studies have reported the relationship between <italic>NRIR</italic>, macrophage polarization, and peri-implantitis. Further elucidation of these underlying mechanisms will enhance our understanding of peri-implantitis pathogenesis and facilitate the development of preventive and therapeutic approaches.</p>
<p>Our previous studies demonstrated significant upregulation of <italic>NRIR</italic> in peri-implantitis soft tissues (<xref ref-type="bibr" rid="B20">20</xref>). The current study further investigates the role of <italic>NRIR</italic> in peri-implantitis-associated macrophage polarization. Through RNA sequencing, we preliminarily identified <italic>RSAD2</italic> as a potential target for <italic>NRIR</italic>. Subsequent <italic>in vitro</italic> experiments revealed that <italic>NRIR</italic> regulates <italic>RSAD2</italic> expression, which in turn influences NF-&#x3ba;B activation and M1 macrophage polarization. Furthermore, supernatants derived from <italic>NRIR</italic>-knockdown macrophages upregulated osteogenic factor expression in bone marrow mesenchymal stem cells (BMSCs) and alleviated inflammation and bone loss in a rat peri-implantitis model. Collectively, this study provides novel insights into peri-implantitis pathogenesis and may inform future strategies for prevention and treatment.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Cell culture and stimulation</title>
<p>The THP-1 human monocytic cell line was purchased from Biospecies (Guangdong, China). THP-1 cells were cultured in Roswell Park Memorial Institute 1640 (RPMI 1640, Procell, Wuhan, China) medium supplemented with 10% fetal bovine serum (FBS, PAN, Aidenbach, Germany) and 1% penicillin-streptomycin (Beyotime, Shanghai, China). To induce differentiation into M1 macrophages, THP-1 cells were stimulated with 200 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma, Shanghai, China) for 24 h to form adherent M0 macrophages, followed by treatment with 100 ng/ml LPS and 20 ng/ml IFN-&#x3b3; for 48 h.</p>
<p>Human mesenchymal stem cells were obtained from Oricell (Guangzhou, China) and cultured in Minimum Essential Medium &#x3b1; (&#x3b1;-MEM, Procell, Wuhan, China) supplemented with 10% FBS and 1% penicillin-streptomycin.</p>
<p>All cell cultures were maintained in Esco CelMate carbon dioxide (CO<sub>2</sub>) incubators (Esco, Singapore) at 37 &#xb0;C under 5% CO<sub>2</sub> conditions to simulate physiological environments.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Cell transfection</title>
<p>Small interfering RNAs (siRNAs) specifically targeting <italic>NRIR</italic> and <italic>RSAD2</italic> were purchased from OBIO (Shanghai, China), with non-targeted siRNA used as negative control (NC). The siRNA and NC sequences are provided in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>. Overexpression plasmids containing full-length RSAD2 and control plasmids were also acquired from OBIO (Shanghai, China); plasmid details are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>.</p>
<p>For siRNA transfection, 5 &#xd7; 10<sup>5</sup> THP-1 cells were seeded into six-well plates and cultured for 24 h, followed by incubation in Opti-MEMI Reduced Serum Medium (31985-070, Gibco, California, USA) for an additional 12 h. Subsequently, 100 pmol of siRNA was transfected into each well using 7.0 &#x3bc;l CALNPTM RNAi reagent A and 2.0 &#x3bc;l CALNPTM RNAi reagent B (D-Nano, Beijing, China).</p>
<p>For plasmid transfection, 5 &#xd7; 10<sup>5</sup> THP-1 cells were seeded into six-well plates for 24 h. Upon reaching approximately 80% confluency, 3 &#x3bc;g of plasmid DNA was transfected per well with 4.8 &#x3bc;l Lipofect5000 reagent and 200 &#x3bc;l Trans buffer (BIOG, Changzhou, China).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>RNA sequencing</title>
<p>Total RNA was isolated from M1 macrophages using TRIzol reagent (Sangon, Shanghai, China) following the manufacturer&#x2019;s instructions. RNA quality assessment, library preparation, sequencing, quality control, mapping reads to the reference genome, and differential gene expression analyses were performed by Novogene Co., Ltd (Beijing, China). For functional annotation, Gene Ontology (GO, <ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org/">http://www.geneontology.org/</ext-link>) and Kyoto Encyclopedia of Genes and Genomes (KEGG, <ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/kegg/">http://www.genome.jp/kegg/</ext-link>) analyses were conducted to elucidate gene functions and relevant pathways associated with differentially expressed genes (DEGs). Gene Set Enrichment Analysis (GSEA) was further performed to identify key KEGG signaling pathways. R software (version 4.40) was utilized to visually represent data through principal component analysis (PCA), volcano plots, heatmaps, and pathway enrichment plots. The RNA-seq data were deposited in the NCBI Sequence Read Archive (SRA) (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra">https://www.ncbi.nlm.nih.gov/sra</ext-link>) (BioProject ID: PRJNA1281584; BioSample accession numbers: SAMN49569226, SAMN49569227, SAMN49569228, SAMN49569229, SAMN49569230, and SAMN49569231).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Quantitative real-time polymerase chain reaction</title>
<p>Total RNA was extracted from THP-1 macrophages and BMSCs using the SteadyPure Rapid RNA Extraction Kit (Accurate Biology, Hunan, China). RNA was reverse-transcribed into complementary DNA (cDNA) using the Evo M-MLV RT Mix Kit (Accurate Biology, Hunan, China). Subsequently, RT-qPCR was performed using SYBR<sup>&#xae;</sup> Green Premix Pro Taq HS RT-qPCR Kit (Accurate biology, Hunan, China), following the manufacturer&#x2019;s instructions. Relative gene expression levels were calculated using the 2<sup>-&#x394;&#x394;Ct</sup> method as described by Livak et&#xa0;al. (<xref ref-type="bibr" rid="B21">21</xref>). Primers synthesized by Sangon Biotech (Shanghai, China) are listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S2</bold>
</xref>.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Western blotting</title>
<p>Total proteins were extracted from THP-1 cells and BMSCs using a total protein extraction kit (Keygen Biotech, Jiangsu, China). Protein concentrations were quantified using a BCA assay Kit (Beyotime, Beijing, China). After centrifugation (12,000 &#xd7; g, 4&#xb0;C, 10 min), protein lysates were separated by 10% or 12.5% SDS-PAGE and transferred onto polyvinylidene fluoride (PVDF) membranes. Membranes were blocked with 5% skimmed milk in Tris-buffered saline containing Tween-20 (TBST) at room temperature for 2 h, then incubated overnight (4&#xb0;C) with primary antibodies against RSAD2 (Proteintech, 28089-1-AP, 1:1000), CD86 (Huabio, ET1606-50, 1:1000), iNOS (Huabio, HA722031, 1:1000), phospho-p65 (CST, 3033 T, 1:1000), p65 (Proteintech, 10745&#x2013;1-AP, 1:1000), phospho-I&#x3ba;B (Huabio, HA722770, 1:1000), I&#x3ba;B (Huabio, ET1603-6, 1:1000), Osteopontin (OPN, Proteintech, 80912-4-RR, 1:4000), osteocalcin (OCN, Bioss, bs-4917R, 1:1000), runt-related transcription factor-2 (RUNX2, Huabio, ET1612-47, 1:5000), and GAPDH (Affinity, AF7021, 1:1000). Subsequently, membranes were washed three times in TBST (10 min each) and incubated with HRP-conjugated secondary antibodies (Goat anti-Rabbit IgG, Proteintech, SA00001-2, 1:4000) at room temperature for 2 h. Protein bands were visualized using enhanced chemiluminescence reagent (Affinity, West Virginia, USA) and an iBright CL1000 imaging system (Thermo, MA, USA). Semi-quantitative analysis of protein expression was performed using ImageJ software (v1.8.0, NIH, MD, USA).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Flow cytometry</title>
<p>Following successful macrophage polarization, THP-1 cells were harvested and filtered to prepare single-cell suspensions. Fc receptor-mediated nonspecific binding was blocked using human Fc receptor blocking solution (TruStain FcX&#x2122;, BioLegend, 422301). Cells were washed three times, stained on ice with PE-conjugated anti-CD86 antibody (Biolegend, 374205) in staining buffer containing 1% FBS, and analyzed using a FACSMelody flow cytometer (BD). Data analysis was performed using FlowJo software (Tree Star).</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Immunofluorescence staining</title>
<p>THP-1 cells were fixed in 4% paraformaldehyde (PFA) for 30 min, permeabilized with 0.5% Triton X-100 for 30 min at room temperature (20&#xb0;C), and blocked with 5% goat serum in phosphate-buffered saline (PBS) for 1.5 h (37&#xb0;C). Subsequently, cells were incubated overnight (4&#xb0;C) with primary antibodies against CD86 (Huabio, ET1606-50, 1:500) and iNOS (Huabio, HA722031, 1:100). After three washes with PBS, cells were incubated with fluorescent secondary antibodies for 1 h (37&#xb0;C, in darkness). Cell nuclei were counterstained with 4&#x2032;,6-diamidino-2-phenylindole (DAPI, Solarbio, Beijing, China). Stained cells were visualized using laser scanning confocal microscopy (BC43 SR, OXFORD, UK).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Macrophage supernatant preparation</title>
<p>M0 macrophages were transfected and subsequently polarized into M1 macrophages using LPS/IFN-&#x3b3; for 48 h. Cells were then washed three times with PBS and cultured in serum-free medium for an additional 24 h. SNs were collected, centrifuged (300 &#xd7; g, 10 min) to remove cellular debris, and filtered (0.22 &#x3bc;m filter). A portion of SNs was combined 1:1 with osteogenic induction medium (Oricell, Guangzhou, China) for BMSC co-culture experiments, and the remainder was used directly for <italic>in vivo</italic> experiments.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Alkaline phosphatase activity and alizarin red S staining</title>
<p>BMSCs underwent osteogenic induction upon reaching 80% confluency. After 14 days, ALP activity was assessed using an ALP staining Kit (Beyotime, Beijing, China). Calcium mineralization was evaluated after 21 days by Alizarin Red S (ARS) staining (Oricell, Guangzhou, China). Chromogenic reactions were visualized using a stereomicroscope (SZN71, SOPTOP, China).</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>
<italic>In vivo</italic> experiment</title>
<p>Thirty male Sprague-Dawley (SD) rats (8 weeks old) were obtained from the Animal Center of Southwest Medical University. All surgical procedures were approved by the Animal Ethics Committee of Southwest Medical University (SWMU20210414) and followed the ARRIVE (Animal Research: Reporting of <italic>In Vivo</italic> Experiments) guidelines.</p>
<p>Detailed surgical procedures were described in our previous studies (<xref ref-type="bibr" rid="B22">22</xref>). Briefly, unilateral maxillary first molars of SD rats were extracted under general anesthesia induced by 4% isoflurane inhalation. After a 4-week healing period, rats were anesthetized similarly, and local anesthesia (articaine with 1:100,000 epinephrine; Primacaine, France) was administered at the surgical site. Gingival incisions were made in the maxillary first molar region, and implant sockets were prepared using a reamer (1.6 mm diameter). Customized Ti-6AL-4V screw-type implants (2mm diameter, 3mm thread length, 1.5mm smooth neck) (<xref ref-type="bibr" rid="B22">22</xref>) were then inserted. Four weeks were allowed for osseointegration. Seven rats were excluded after four weeks due to death (n = 3) or implant loosening (n = 4). The remaining rats were randomly allocated into four groups using a random number table: (a) control group (n = 5); (b) LPS group (n = 6); (c) si-NC-SN group (n = 6); and (d) si-<italic>NRIR</italic>-SN group (n = 6).</p>
<p>Different treatments were applied to each group. In the LPS group, LPS derived from <italic>P. gingivalis</italic> (1 mg/mL, 10 &#xb5;L per injection) was injected into the gingival sulcus around implants every three days for two weeks to establish peri-implantitis (<xref ref-type="bibr" rid="B23">23</xref>). PBS replaced LPS injections in the control group. Considering rats lack the <italic>NRIR</italic> gene, direct knockdown via vectors (such as nanoparticle- or adenovirus-mediated siRNA transfer) was infeasible. Referring to prior studies (Tahmasebi et&#xa0;al., Ma et&#xa0;al.) (<xref ref-type="bibr" rid="B24">24</xref>&#x2013;<xref ref-type="bibr" rid="B26">26</xref>), we chose macrophage-secreted supernatants (SN) as media to investigate <italic>NRIR</italic>&#x2019;s role in animal models. Rats in the si-NC-SN group received SN from M1 macrophages transfected with non-targeting siRNA, while those in the si-<italic>NRIR</italic>-SN group received SN from <italic>NRIR</italic> siRNA-transfected M1 macrophages. SN (200 &#xb5;L) was injected into both buccal and lingual gingiva around implants every 3 days for 2 weeks. Rats were sacrificed four weeks post-injection, and tissues were harvested for analysis.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Micro-computed tomography</title>
<p>Maxillae were scanned using micro-CT (Inveon PET CT, Siemens, Germany) with the following parameters: spot size (50 &#xb5;m), tube voltage (80 kVp), tube current (500 &#xb5;A), and total rotation (360&#xb0;). Three-dimensional (3D) reconstructions were analyzed using Mimics (version 21.0) software. Peri-implant bone loss was assessed by measuring the distance from the most coronal marginal bone position to the apical implant head at distal, mesial, buccal, and palatal locations. Bone mineral density (BMD), trabecular thickness (Tb.Th), bone volume fraction (BV/TV), trabecular separation (Tb.Sp), and trabecular number (Tb.N) were quantified according to the micro-CT analysis guidelines outlined by Huang et&#xa0;al. (<xref ref-type="bibr" rid="B27">27</xref>).</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Immunohistochemical analysis</title>
<p>Maxillary alveolar bone specimens were fixed in 4% paraformaldehyde and decalcified for 6 weeks 10% ethylene diamine tetraacetic acid (EDTA, Solarbio, Beijing, China). Subsequently, specimens were sectioned into 4 &#xb5;m slices (proximal-distal direction), blocked with 5% BSA for 1h, and incubated with primary antibodies overnight (4&#xb0;C) according to manufacturer protocols. Slices were then incubated with DAB chromogenic solution, counterstained with hematoxylin (3 min), and visualized under an Olympus BX51 microscope (Tokyo, Japan). Semi-quantitative analysis was conducted using ImageJ software (v1.8.0, NIH, MD, USA). Staining intensity was quantified by calculating average optical density (AOD) as the ratio of integrated optical density (IntDen) of positively stained regions to the area (AOD = IntDen/Area).</p>
</sec>
<sec id="s2_13">
<label>2.13</label>
<title>Statistical analysis</title>
<p>Statistical significance was assessed using two-tailed Student&#x2019;s t-test or one-way ANOVA. Where ANOVA showed significant differences, Student-Newman-Keuls q (SNK-q) <italic>post-hoc</italic> tests were performed to identify statistically significant pairwise differences. Variables not meeting normal distribution criteria were analyzed using the Kruskal&#x2013;Wallis H test. Statistical analyses were performed using SPSS software (version 27.0, SPSS Inc., Chicago, USA). Quantitative data are presented as mean &#xb1; standard deviation (SD). Differences were considered statistically significant at P &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>LncRNA <italic>NRIR</italic> participates in M1 macrophage polarization in peri-implantitis</title>
<p>In our previous study, high-throughput transcriptome sequencing identified lncRNA <italic>NRIR</italic> in gingival tissues from peri-implantitis patients. <italic>NRIR</italic> may critically contribute to peri-implant inflammation (<xref ref-type="bibr" rid="B20">20</xref>). Additionally, seven genes (<italic>RSAD2, CMPK2, IFIT1, IFIT3, ISG15, BST2, and HLA-C</italic>) were predicted as potential <italic>NRIR</italic> targets (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>Since macrophages are pivotal immune cells in peri-implantitis, we hypothesized that <italic>NRIR</italic> might regulate macrophage polarization. To test this hypothesis, we analyzed M1 macrophages and observed that <italic>NRIR</italic> was significantly upregulated (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). Next, we used specific siRNA to silence <italic>NRIR</italic> and evaluated its influence on M1 macrophage activation. RT-qPCR results indicated significant downregulation of M1-associated genes (<italic>IL-1&#x3b2;, IL-6, iNOS, CD86, and CXCL10</italic>) following <italic>NRIR</italic> knockdown (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Western blotting demonstrated reduced CD86 protein expression in <italic>NRIR</italic>-knockdown macrophages (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). Flow cytometry analysis revealed that <italic>NRIR</italic> knockdown significantly decreased M1 polarization, as indicated by CD86 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Additionally, IF assays confirmed that <italic>NRIR</italic> silencing markedly inhibited expression of M1 macrophage polarization markers (iNOS, CD86) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>LncRNA <italic>NRIR</italic> involvement in M1 macrophage polarization. <bold>(A)</bold> <italic>NRIR</italic> expression levels in M0 and M1 macrophages. <bold>(B)</bold> RT-qPCR analysis of <italic>NRIR</italic> and M1 polarization-related genes (<italic>IL-1&#x3b2;, IL-6, iNOS, CD86, CXCL10</italic>) after <italic>NRIR</italic> knockdown. <bold>(C)</bold> Western blot analysis of CD86 protein expression after <italic>NRIR</italic> knockdown. <bold>(D)</bold> Flow cytometry evaluation of CD86-positive macrophages following <italic>NRIR</italic> knockdown. <bold>(E)</bold> IF staining of CD86 and iNOS after <italic>NRIR</italic> knockdown. Data represent means &#xb1; SD, n = 3; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g001.tif">
<alt-text content-type="machine-generated">Graphical data showcasing the effects of si-NRIR on different markers. Images A and B depict bar graphs indicating relative RNA levels under various conditions, displaying significant differences denoted by asterisks. Image C shows a Western blot for CD86 and GAPDH proteins, accompanied by a bar graph comparing CD86 expression levels. Image D features histograms of CD86 cell ratios, highlighting differences between si-NC and si-NRIR. Image E contains immunofluorescence images for iNOS and CD86 with DAPI-stained nuclei, alongside heatmaps illustrating expression intensity. Scale bar in the fluorescence images represents fifty micrometers.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>
<italic>RSAD2</italic> is a potential target of <italic>NRIR</italic> regulating macrophage polarization</title>
<p>To further explore the mechanisms underlying <italic>NRIR</italic>-mediated macrophage activation, we performed transcriptome microarray and bioinformatics analyses on M1 macrophages after <italic>NRIR</italic> knockdown. PCA and heatmap analyses demonstrated distinct transcriptomic profiles between control and <italic>NRIR</italic>-knockdown groups, indicating significant gene expression alterations (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). Differential expression analysis identified 729 DEGs (357 downregulated, 372 upregulated), visualized by a volcano plot (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). GSEA enrichment indicated general downregulation of the NF-&#x3ba;B signaling pathway in <italic>NRIR</italic>-knockdown macrophages (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>). Additionally, intersection analysis between DEGs and predicted <italic>NRIR</italic> targets identified <italic>RSAD2</italic> as the only overlapping gene (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). Preliminary characterization demonstrated that RSAD2 was downregulated following <italic>NRIR</italic> knockdown at both mRNA and protein levels, whereas <italic>RSAD2</italic> knockdown did not affect <italic>NRIR</italic> expression (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2F, G</bold>
</xref>). Thus, we strongly suspected <italic>RSAD2</italic> as a potential target of <italic>NRIR</italic> in macrophage polarization regulation.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Transcriptomic analysis of macrophage polarization after <italic>NRIR</italic> knockdown. <bold>(A)</bold> PCA plot of transcriptomic profiles. <bold>(B)</bold> Heatmap depicting DEGs. <bold>(C)</bold> Volcano plot illustrating significantly upregulated (red), downregulated (blue), and unchanged (gray) genes. <bold>(D)</bold> GSEA. <bold>(E)</bold> Venn diagram comparing DEGs and predicted <italic>NRIR</italic> targets genes. <bold>(F)</bold> RT-qPCR analysis of <italic>NRIR</italic> and RSAD2 expression. <bold>(G)</bold> Western blot analysis of RSAD2 protein after <italic>NRIR</italic> knockdown. Data represent means &#xb1; SD, n = 3; **P &lt; 0.01; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g002.tif">
<alt-text content-type="machine-generated">Panel A displays a PCA plot showing si-NC and si-NRIR groups. Panel B is a heatmap of gene expression with hierarchical clustering. Panel C is a volcano plot illustrating gene expression changes. Panel D shows a ridge plot of pathways influenced, with NF-kappa B signaling highlighted. Panel E is a Venn diagram showing overlap of significant genes and NRIR targets with RSAD2. Panel F presents bar graphs of RNA levels for RSAD2 and NRIR, highlighting significant reduction in RSAD2 with si-NRIR. Panel G includes a Western blot and bar graph depicting reduced RSAD2 protein levels with si-NRIR intervention.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>
<italic>RSAD2</italic> regulates M1 macrophage polarization</title>
<p>To investigate the role of <italic>RSAD2</italic> in M1 macrophages, <italic>RSAD2</italic>-knockdown macrophages were evaluated. At the genetic level, M1-associated genes (<italic>IL-1&#x3b2;, IL-6, iNOS, CD86, and CXCL10</italic>) were significantly downregulated (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). At the protein level, <italic>RSAD2</italic>-knockdown macrophages showed reduced expression of RSAD2 and CD86 (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Flow cytometry results demonstrated that <italic>RSAD2</italic> knockdown markedly reduced M1 polarization (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Moreover, IF confirmed that <italic>RSAD2</italic> silencing effectively suppressed the expression of M1 macrophage polarization markers (iNOS, CD86) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<italic>RSAD2</italic> regulates macrophage polarization. <bold>(A)</bold> RT-qPCR analysis of <italic>RSAD2</italic>, and M1 polarization-related genes (<italic>IL-1&#x3b2;, IL-6, iNOS, CD86, CXCL10</italic>) after <italic>RASD2</italic> knockdown. <bold>(B)</bold> Western blot analysis of RSAD2 and CD86 protein levels after <italic>RSAD2</italic> knockdown. <bold>(C)</bold> Flow cytometry analysis of CD86-positive cells after <italic>RSAD2</italic> knockdown. <bold>(D)</bold> IF staining of CD86 and iNOS after <italic>RSAD2</italic> knockdown. Graphs represent means &#xb1; SD, n = 3; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g003.tif">
<alt-text content-type="machine-generated">Graphs, blots, and microscopy images analyze RSAD2 gene knockdown effects. Panel A shows bar graphs of RNA levels for RSAD2, IL-1&#x3b2;, IL-6, iNOS, CD86, and CXCL10. Panel B displays Western blots for CD86, RSAD2, and GAPDH with corresponding protein quantification. Panel C includes flow cytometry histograms for CD86 expression, indicating percentage differences. Panel D contains fluorescence microscopy images of iNOS and CD86, with DAPI-stained nuclei, and heatmaps for visualization. Statistical significance is denoted with asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>LncRNA <italic>NRIR</italic> promotes M1 macrophage activation by enhancing RSAD2 gene expression</title>
<p>To confirm whether <italic>NRIR</italic> exerts its effects by regulating <italic>RSAD2</italic>, a rescue assay was conducted. Plasmids targeting <italic>RSAD2</italic> were transfected into THP-1 macrophages with confirmed <italic>NRIR</italic> knockdown to restore <italic>RSAD2</italic> expression. Results indicated that <italic>RSAD2</italic> overexpression reversed the reduced gene and protein expression associated with M1 macrophages caused by <italic>NRIR</italic> knockdown (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A, B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>
<italic>NRIR</italic> regulates macrophage polarization by enhancing <italic>RSAD2</italic>. <bold>(A)</bold> RT-qPCR analysis of <italic>NRIR</italic>, <italic>RSAD2</italic>, and M1 polarization-related genes after co-transfection. <bold>(B)</bold> Western blot analysis of CD86 and RSAD2 proteins after co-transfection. Graphs represent means &#xb1; SD, n = 3; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001; ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g004.tif">
<alt-text content-type="machine-generated">Bar graphs and Western blot images compare RNA and protein expression levels across different conditions. Graph A shows relative RNA levels of NRIR, RSAD2, IL-1&#x3b2;, IL-6, INOS, CD86, and CXCL10, with significant differences indicated by asterisks. Graph B displays protein expression levels of CD86 and RSAD2, showing variations across si-NC+oe-NC, si-NRIR+oe-NC, and si-NRIR+oe-RSAD2 conditions. GAPDH serves as a loading control.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Knockdown of lncRNA <italic>NRIR</italic> inhibits NF-&#x3ba;B signaling by downregulating <italic>RSAD2</italic> during macrophages polarization</title>
<p>We subsequently investigated signaling pathways regulated by <italic>NRIR</italic> during macrophage polarization. GSEA indicated that <italic>NRIR</italic> knockdown inhibited the NF-&#x3ba;B signaling pathway (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>). The NF-&#x3ba;B pathway is essential for M1 macrophage activation, particularly in regulating inflammatory gene expression (<xref ref-type="bibr" rid="B28">28</xref>). Western blot analysis assessed phosphorylated forms of key factors, I&#x3ba;B and p65. Results showed that <italic>NRIR</italic> knockdown reduced phosphorylated I&#x3ba;B, phosphorylated p65, and CD86 levels in M1 macrophages. However, this reduction was reversed by treating cells with Diprovocim, a potent TLR1/TLR2 agonist that activates NF-&#x3ba;B signaling downstream (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>
<italic>NRIR</italic> activates NF-KB signaling by regulating <italic>RSAD2</italic>, promoting M1 macrophage activation <bold>(A)</bold> Western blot analysis showing phospho-p65, p65, phospho-I&#x3ba;B, I&#x3ba;B, and CD86 protein levels after <italic>NRIR</italic> knockdown. <bold>(B)</bold> Western blot analysis of the same proteins after RSAD2 knockdown. Data represent means &#xb1; SD, n = 3; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001, ns: not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g005.tif">
<alt-text content-type="machine-generated">Western blot analysis and bar graphs show the expression of proteins phospho-p65, p65, phospho-I&#x3ba;B, I&#x3ba;B, and CD86, with GAPDH as the loading control. Panel A compares si-NC, si-NRIR, and si-NRIR with Diprovocim groups, while Panel B compares si-NC, si-RSAD2, and si-RSAD2 with Diprovocim groups. Relative expression levels are quantified in the bar graphs, indicating significant changes marked by asterisks representing statistical significance.</alt-text>
</graphic>
</fig>
<p>To confirm whether <italic>NRIR</italic> regulates NF-&#x3ba;B signaling via <italic>RSAD2</italic>, we evaluated <italic>RSAD2</italic>-knockdown macrophages. Protein levels of phosphorylated I&#x3ba;B, phosphorylated p65, and CD86 decreased in <italic>RSAD2</italic>-knockdown macrophages during M1 activation. These findings indicate that <italic>NRIR</italic> depletion suppresses NF-kB signaling by downregulating <italic>RSAD2</italic>, further attenuating M1 macrophage polarization (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>).</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Macrophage with <italic>NRIR</italic> knockdown promote osteogenic differentiation of BMSCs <italic>in vitro</italic>
</title>
<p>Chemokines and cytokines secreted by macrophages regulate MSC migration and differentiation for bone regeneration (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>). To evaluate effects of factors secreted by <italic>NRIR</italic>-knockdown macrophages on BMSC osteogenic differentiation, conditioned medium from <italic>NRIR</italic>-knockdown M1 macrophages was used to culture BMSCs. RT-qPCR and Western blotting showed that <italic>NRIR</italic>-knockdown macrophage supernatants significantly increased expression of osteogenic differentiation markers (OCN, OPN, RUNX2) in BMSCs compared to control groups (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>). ALP staining demonstrated enhanced ALP expression in BMSCs cultured with <italic>NRIR</italic>-knockdown macrophage supernatants (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). ARS staining showed that BMSCs cultured with <italic>NRIR</italic>-knockdown macrophage supernatants formed more mineralized nodules (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>
<italic>NRIR</italic> knockdown in macrophages enhances osteogenic differentiation in BMSCs. <bold>(A)</bold> RT-qPCR analysis of <italic>OCN</italic>, <italic>OPN</italic>, <italic>ALP</italic>, and <italic>RUNX2</italic> mRNA levels. <bold>(B)</bold> Western blot analysis of OCN, OPN, and RUNX2 protein levels. <bold>(C)</bold> ALP staining after 14 days of osteogenic induction. <bold>(D)</bold> ARS staining after 21 days of osteogenic induction. Data represent means &#xb1; SD, n = 3; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g006.tif">
<alt-text content-type="machine-generated">Panel A shows a bar graph comparing the relative RNA levels of OCN, OPN, ALP, and RUNX2 between si-NC and si-NRIR, with higher levels in si-NRIR. Panel B displays Western blot images for OPN, RUNX2, OCN, and GAPDH with corresponding bar graphs, indicating increased protein expression in si-NRIR. Panels C and D present microscopic images comparing cellular morphology and staining between si-NC-SN and si-NRIR-SN, showing denser staining in si-NRIR-SN with a scale bar of two hundred micrometers.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Supernatants from <italic>NRIR</italic>-knockdown M1 macrophages reduce inflammation and bone loss in a rat peri-implantitis model</title>
<p>Next, we explored the role of <italic>NRIR</italic> in peri-implantitis using a rat model. Clinical observations showed that supernatants from macrophages transfected with si-NC produced clinical manifestations similar to LPS-induced peri-implantitis. However, inflammation was significantly lower in rats treated with supernatants from macrophages transfected with si-<italic>NRIR</italic> (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). Micro-CT revealed that bone loss in the si-NC-SN group and LPS group was comparable, whereas bone resorption was significantly lower in the si-<italic>NRIR</italic> group (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). Bone morphometric analysis demonstrated significantly increased BMD, BV/TV, Tb.N, and Tb.Th and decreased Tb.Sp in the si-<italic>NRIR</italic>-SN group compared to the si-NC-SN group (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). Additionally, histological analyses showed similar inflammatory infiltration and bone resorption in the LPS and si-NC-SN groups, whereas the si-<italic>NRIR</italic>-SN group had reduced inflammatory cytokine expression (IL-1&#x3b2;, IL-6, TNF-&#x3b1;) and elevated osteogenic marker expression (RUNX2, OPN, OCN) (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7D, E</bold>
</xref>). Together, <italic>NRIR</italic> knockdown modifies supernatant composition, reducing peri-implant inflammation and bone loss.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Intraoral images of rats and immunohistochemical analysis of peri-implant tissues. <bold>(A)</bold> Intraoral images from peri-implantitis model rats. <bold>(B)</bold> Maxillary Micro-CT images of each group. <bold>(C)</bold> Bone loss and bone morphometric parameters (BMD, Tb.N, BV/TV, Tb.Th, Tb.Sp) quantified in each group. <bold>(D)</bold> Representative IHC images and semi-quantitative analyses of IL-1&#x3b2;, IL-6, and TNF-&#x3b1; in peri-implant tissues. <bold>(E)</bold> Representative IHC images and semi-quantitative analyses of RUNX2, OPN, and OCN in peri-implant tissues. AB, alveolar bone; IM, implant; AOD, average optical density. Data represent means &#xb1; SD, n = 5; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001, ns, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g007.tif">
<alt-text content-type="machine-generated">Figure composed of four panels showing experimental results. Panel A displays images of dental implants in four conditions: Control, LPS, si-NC-SN, and si-NRIR-SN. Panel B features radiographic sections&#x2014;sagittal, transverse, and coronal&#x2014;of implants under the same conditions. Panel C presents bar graphs comparing various metrics like the distance of implant-bone edge, BMD, Tb.N, BV/TV, Tb.Th, Tb.Sp across conditions, with statistical significance indicated. Panel D includes immunohistochemical staining for IL-1&#x3b2;, IL-6, and TNF-&#x3b1;, with corresponding graph. Panel E shows staining for RUNX2, OPN, and OCN, with respective bar graph.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Over the past few decades, lncRNAs were considered transcriptional &#x201c;junk&#x201d; because they do not encode proteins (<xref ref-type="bibr" rid="B32">32</xref>). However, recent studies have demonstrated that lncRNAs play critical roles in the activation and function of differentially polarized macrophages in cancer, inflammation, and cardiovascular diseases (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). The present study identified lncRNA-<italic>NRIR</italic>, which regulated <italic>RSAD2</italic> and was highly expressed during M1 macrophage activation. Using loss-of-function approaches, <italic>NRIR</italic> was determined to be a positive regulator of M1 macrophage activation in peri-implantitis. <italic>NRIR</italic> promotes NF-&#x3ba;B activation through <italic>RSAD2</italic>, reduces osteogenesis-related factors in BMSCs, and promotes inflammation-induced bone resorption in peri-implantitis (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>). These findings suggest a novel regulatory pathway for M1 macrophage activation, providing new insights into peri-implantitis pathogenesis.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Schematic model of lncRNA <italic>NRIR</italic> functions in M1 macrophage activation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1650984-g008.tif">
<alt-text content-type="machine-generated">Diagram illustrating the cellular signaling pathway involving the TLR4 receptor and IFN-&#x3b3;R leading to activation of NF-kB p65 and RSAD2 expression. It shows interactions influencing macrophage activation and bone marrow stromal cells (BMSCs), resulting in reduced expression of OCN, OPN, and RUNX2. This process leads to decreased bone formation, depicted with directional arrows and labeled components.</alt-text>
</graphic>
</fig>
<p>
<italic>NRIR</italic> is located on chromosome 2p25.2 and is closely associated with the type I IFN pathway (<xref ref-type="bibr" rid="B35">35</xref>). Previous studies have identified <italic>NRIR</italic> as a potential biomarker for systemic lupus erythematosus (SLE), where it may contribute to disease progression (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>). However, its roles and molecular mechanisms in other diseases, especially macrophage-related conditions, remain poorly understood. A recent report indicated <italic>NRIR</italic> is strongly induced in macrophages during Mtb infection (<xref ref-type="bibr" rid="B36">36</xref>). In our study, <italic>NRIR</italic> was similarly induced in LPS/IFN-&#x3b3;-stimulated M1 macrophages.</p>
<p>
<italic>RSAD2</italic> is an interferon-stimulated gene (ISG) encoding the protein viperin, known for antiviral activity (<xref ref-type="bibr" rid="B37">37</xref>). Emerging studies emphasize the critical roles of RSAD2/viperin in immunomodulation and mitochondrial metabolism (<xref ref-type="bibr" rid="B38">38</xref>&#x2013;<xref ref-type="bibr" rid="B41">41</xref>). Although <italic>RSAD2</italic> expression was significantly increased in polarized human THP-1 and mouse RAW264.7 macrophage models, its precise role in M1 macrophage activation remains unclear (<xref ref-type="bibr" rid="B42">42</xref>). Our study revealed that RSAD2/viperin participates in M1 macrophage activation. Moreover, based on previous high-throughput sequencing data and the findings of Cao et&#xa0;al., we verified <italic>NRIR</italic> regulates <italic>RSAD2</italic>, influencing macrophage polarization (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>As a pivotal inflammatory regulator, nuclear factor kappa-B (NF-&#x3ba;B) promotes the transcription of pro-inflammatory cytokine genes (<xref ref-type="bibr" rid="B44">44</xref>). Previous studies confirmed that NF-&#x3ba;B signaling regulates macrophage polarization (<xref ref-type="bibr" rid="B45">45</xref>&#x2013;<xref ref-type="bibr" rid="B47">47</xref>). Transcriptome analysis from <italic>NRIR</italic>-knockdown M1 macrophages demonstrated significant down-regulation of NF-&#x3ba;B signaling. Subsequent experiments provided strong evidence that <italic>NRIR</italic> activates NF-&#x3ba;B signaling through <italic>RSAD2</italic>.</p>
<p>The immune and skeletal systems contribute to peri-implantitis by exchanging cytokines, transcription factors, and signaling receptors (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>). Macrophages, key immune cells, specifically regulate bone homeostasis. Conversely, BMSCs, major osteoblast progenitors, differentiate into osteoblasts under appropriate conditions, enhancing osteogenesis (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Pro-inflammatory M1 macrophages secrete various cytokines (TNF-&#x3b1;, IL-1, IL-12, IFN-&#x3b3;), chemokines, and matrix metalloproteinases, promoting osteoclastogenesis, tissue erosion, and progressive bone destruction (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Based on this principle, supernatants derived from M1 macrophages were utilized to induce peri-implantitis. The results showed that peri-implantitis induced by si-NC macrophage supernatant resulted in a degree of bone loss equivalent to that induced by LPS. Nevertheless, low TNF-&#x3b1; concentrations (20 ng/mL) promote favorable osteogenic outcomes (<xref ref-type="bibr" rid="B53">53</xref>). In our experiments, supernatants obtained from <italic>NRIR</italic>-knockdown M1 macrophages enhanced the expression of osteogenic differentiation markers in BMSCs and alleviated inflammation and bone loss around implants <italic>in vivo</italic>. This beneficial effect may be attributed to alterations in cytokine concentrations that promote the differentiation of BMSCs into osteoblasts.</p>
<p>In clinical settings, how to effectively treat patients by targeting <italic>NRIR</italic> is an important consideration. In recent years, gene knockdown has been achieved through RNA interference technology induced by siRNA, opening new avenues for innovative treatments for various diseases (<xref ref-type="bibr" rid="B54">54</xref>). Although siRNA-based therapy holds significant promise, its clinical application requires addressing limitations related to targeted delivery, off-target effects, and immunogenicity (<xref ref-type="bibr" rid="B55">55</xref>). Several strategies are currently employed to overcome these challenges. Studies have shown that viral vectors, lipid nanoparticles, chemical modifications, or tri-GalNAc conjugates can precisely deliver oligonucleotides to target sites (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). Replacing 2&#x2019;-O-Me at specific nucleotide sites in the seed region effectively inhibits off-target activity of siRNA (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>). Designing siRNA molecules with specific structural modifications can reduce immune activation (<xref ref-type="bibr" rid="B60">60</xref>&#x2013;<xref ref-type="bibr" rid="B64">64</xref>). Thus, siRNA targeting <italic>NRIR</italic> represents a promising treatment strategy for peri-implantitis.</p>
<p>However, this study has several limitations. First, the THP-1 cell line used does not fully reflect the behavior of primary macrophages in peri-implantitis. Second, although the rat peri-implantitis model is ideal, it cannot completely replicate human peri-implantitis pathology. Given these limitations and shortcomings, future research should focus on primary human macrophages and further explore these findings through non-human primate models.</p>
<p>In summary, this study elucidates the <italic>NRIR</italic>/<italic>RSAD2</italic>/NF-&#x3ba;B pathway regulating M1 macrophage activation, suggesting potential therapeutic targets for peri-implantitis prevention and treatment. Our findings provide clinically relevant theoretical insights into macrophage polarization regulation associated with peri-implantitis pathogenesis.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>
<italic>NRIR</italic> acts as a pro-inflammatory regulator in peri-implantitis. It activates the NF-&#x3ba;B signaling pathway by up-regulating <italic>RSAD2</italic>, promoting M1 macrophage activation, and consequently inhibits osteogenic differentiation in BMSCs. These findings provide novel insights into the pathogenesis of peri-implantitis.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the NCBI Sequence Read Archive (SRA) repository (<uri xlink:href="https://www.ncbi.nlm.nih.gov/sra">https://www.ncbi.nlm.nih.gov/sra</uri>), accession number SAMN49569226, SAMN49569227, SAMN49569228, SAMN49569229, SAMN49569230, and SAMN49569231, here: <uri xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1281584">https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA1281584</uri>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by the Animal Ethics Committee of Southwest Medical University. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>RZ: Conceptualization, Supervision, Writing &#x2013; review &amp; editing, Methodology, Writing &#x2013; original draft. LW: Writing &#x2013; review &amp; editing, Methodology, Conceptualization. YZ: Methodology, Writing &#x2013; review &amp; editing, Formal Analysis. KX: Writing &#x2013; review &amp; editing, Methodology, Supervision. QL: Writing &#x2013; review &amp; editing, Methodology. KY: Conceptualization, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the Science and Technology Planning Project of Luzhou City (2024SYF130) and the Innovative Leader Talent Programme of the Affiliated Stomatological Hospital of Southwest Medical University (2024LJ04).</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2025.1650984/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2025.1650984/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF1" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet2.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berglundh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Armitage</surname> <given-names>G</given-names>
</name>
<name>
<surname>Araujo</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Avila-Ortiz</surname> <given-names>G</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>J</given-names>
</name>
<name>
<surname>Camargo</surname> <given-names>PM</given-names>
</name>
<etal/>
</person-group>. <article-title>Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions</article-title>. <source>J Clin Periodontol</source>. (<year>2018</year>) <volume>45 Suppl 20</volume>:<page-range>S286&#x2013;s91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcpe.12957</pub-id>, PMID: <pub-id pub-id-type="pmid">29926491</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berglundh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Mombelli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schwarz</surname> <given-names>F</given-names>
</name>
<name>
<surname>Derks</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Etiology, pathogenesis and treatment of peri-implantitis: A european perspective</article-title>. <source>Periodontol</source>. (<year>2000</year>) <volume>2024)</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/prd.12549</pub-id>, PMID: <pub-id pub-id-type="pmid">38305506</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Gibon</surname> <given-names>E</given-names>
</name>
<name>
<surname>Gallo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Takagi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Macrophage polarization and the osteoimmunology of periprosthetic osteolysis</article-title>. <source>Curr Osteoporos Rep</source>. (<year>2022</year>) <volume>20</volume>:<fpage>43</fpage>&#x2013;<lpage>52</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11914-022-00720-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35133558</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Enhanced activity of the macrophage M1/M2 phenotypes and phenotypic switch to M1 in periodontal infection</article-title>. <source>J Periodontol</source>. (<year>2016</year>) <volume>87</volume>:<page-range>1092&#x2013;102</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1902/jop.2016.160081</pub-id>, PMID: <pub-id pub-id-type="pmid">27177291</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palevski</surname> <given-names>D</given-names>
</name>
<name>
<surname>Levin-Kotler</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Kain</surname> <given-names>D</given-names>
</name>
<name>
<surname>Naftali-Shani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Landa</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ben-Mordechai</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Loss of macrophage wnt secretion improves remodeling and function after myocardial infarction in mice</article-title>. <source>J Am Heart Assoc</source>. (<year>2017</year>) <volume>6</volume>(<issue>1</issue>):<elocation-id>e004387</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/jaha.116.004387</pub-id>, PMID: <pub-id pub-id-type="pmid">28062479</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Immune dysregulation and macrophage polarization in peri-implantitis</article-title>. <source>Front Bioeng Biotechnol</source>. (<year>2024</year>) <volume>12</volume>:<elocation-id>1291880</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fbioe.2024.1291880</pub-id>, PMID: <pub-id pub-id-type="pmid">38347915</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cutolo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Campitiello</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gotelli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Soldano</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>867260</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.867260</pub-id>, PMID: <pub-id pub-id-type="pmid">35663975</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Macrophage polarization and the regulation of bone immunity in bone homeostasis</article-title>. <source>J Inflammation Res</source>. (<year>2023</year>) <volume>16</volume>:<page-range>3563&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/jir.S423819</pub-id>, PMID: <pub-id pub-id-type="pmid">37636272</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Macrophages regulate the progression of osteoarthritis</article-title>. <source>Osteoarthritis Cartilage</source>. (<year>2020</year>) <volume>28</volume>:<page-range>555&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.joca.2020.01.007</pub-id>, PMID: <pub-id pub-id-type="pmid">31982565</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Polarized macrophages in periodontitis: characteristics, function, and molecular signaling</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>763334</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.763334</pub-id>, PMID: <pub-id pub-id-type="pmid">34950140</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galarraga-Vinueza</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Obreja</surname> <given-names>K</given-names>
</name>
<name>
<surname>Khoury</surname> <given-names>C</given-names>
</name>
<name>
<surname>Begic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ramanauskaite</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sculean</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Influence of macrophage polarization on the effectiveness of surgical therapy of peri-implantitis</article-title>. <source>Int J Implant Dent</source>. (<year>2021</year>) <volume>7</volume>:<fpage>110</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40729-021-00391-2</pub-id>, PMID: <pub-id pub-id-type="pmid">34767122</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fretwurst</surname> <given-names>T</given-names>
</name>
<name>
<surname>Garaicoa-Pazmino</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nelson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Giannobile</surname> <given-names>WV</given-names>
</name>
<name>
<surname>Squarize</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Larsson</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of macrophages infiltrating peri-implantitis lesions</article-title>. <source>Clin Oral Implants Res</source>. (<year>2020</year>) <volume>31</volume>:<page-range>274&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/clr.13568</pub-id>, PMID: <pub-id pub-id-type="pmid">31876318</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engreitz</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Ollikainen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Guttman</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Long non-coding rnas: spatial amplifiers that control nuclear structure and gene expression</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2016</year>) <volume>17</volume>:<page-range>756&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm.2016.126</pub-id>, PMID: <pub-id pub-id-type="pmid">27780979</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>ZT</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>MM</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>KS</given-names>
</name>
<etal/>
</person-group>. <article-title>New insights into the interplay between long non-coding rnas and rna-binding proteins in cancer</article-title>. <source>Cancer Commun (Lond)</source>. (<year>2022</year>) <volume>42</volume>:<page-range>117&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cac2.12254</pub-id>, PMID: <pub-id pub-id-type="pmid">35019235</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname> <given-names>K</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W</given-names>
</name>
<name>
<surname>You</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>The research progress of lncrna involved in the regulation of inflammatory diseases</article-title>. <source>Mol Immunol</source>. (<year>2018</year>) <volume>101</volume>:<page-range>182&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molimm.2018.05.030</pub-id>, PMID: <pub-id pub-id-type="pmid">30007227</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Acharya</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Long non-coding rna and mrna expression profiles in peri-implantitis vs periodontitis</article-title>. <source>J Periodontal Res</source>. (<year>2020</year>) <volume>55</volume>:<page-range>342&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jre.12718</pub-id>, PMID: <pub-id pub-id-type="pmid">31853997</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>962393</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.962393</pub-id>, PMID: <pub-id pub-id-type="pmid">35967341</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Lncrna NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression</article-title>. <source>Lupus</source>. (<year>2024</year>) <volume>33</volume>:<page-range>1538&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/09612033241294032</pub-id>, PMID: <pub-id pub-id-type="pmid">39428741</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muntyanu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Le</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ridha</surname> <given-names>Z</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname> <given-names>E</given-names>
</name>
<name>
<surname>Litvinov</surname> <given-names>IV</given-names>
</name>
<name>
<surname>Lefran&#xe7;ois</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Novel role of long non-coding rnas in autoimmune cutaneous disease</article-title>. <source>J Cell Commun Signal</source>. (<year>2022</year>) <volume>16</volume>:<fpage>487</fpage>&#x2013;<lpage>504</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12079-021-00639-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34346026</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Long non-coding rna NRIR inhibits osteogenesis in peri-implantitis by promoting nlrp3 inflammasome-mediated macrophage pyroptosis</article-title>. <source>Int Immunopharmacol</source>. (<year>2025</year>) <volume>148</volume>:<elocation-id>114180</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2025.114180</pub-id>, PMID: <pub-id pub-id-type="pmid">39874847</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Schmittgen</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta C(T)) method</article-title>. <source>Methods</source>. (<year>2001</year>) <volume>25</volume>:<page-range>402&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>, PMID: <pub-id pub-id-type="pmid">11846609</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>QQ</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>WW</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>PZ</given-names>
</name>
<etal/>
</person-group>. <article-title>A gp130-targeting small molecule, lmt-28, reduces lps-induced bone resorption around implants in diabetic models by inhibiting il-6/gp130/jak2/stat3 signaling</article-title>. <source>Mediators Inflammation</source>. (<year>2023</year>) <volume>2023</volume>:<elocation-id>9330439</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2023/9330439</pub-id>, PMID: <pub-id pub-id-type="pmid">36643585</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirih</surname> <given-names>FQ</given-names>
</name>
<name>
<surname>Hiyari</surname> <given-names>S</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Barroso</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Jorge</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Perussolo</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>A murine model of lipopolysaccharide-induced peri-implant mucositis and peri-implantitis</article-title>. <source>J Oral Implantol</source>. (<year>2015</year>) <volume>41</volume>:<page-range>e158&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1563/aaid-joi-D-14-00068</pub-id>, PMID: <pub-id pub-id-type="pmid">24967609</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tahmasebi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Asl</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Faghihi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bolandi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Barati</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Synergistic effects of olfactory ecto-mesenchymal stem cell supernatant and ellagic acid on demyelination and glial modulation in a chronic multiple sclerosis model</article-title>. <source>Cell Mol Neurobiol</source>. (<year>2025</year>) <volume>45</volume>:<fpage>40</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10571-025-01558-w</pub-id>, PMID: <pub-id pub-id-type="pmid">40314717</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tahmasebi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Asl</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Vahidinia</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Faghihi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Barati</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>The comparative effects of bone marrow mesenchymal stem cells and supernatant transplantation on demyelination and inflammation in cuprizone model</article-title>. <source>Mol Biol Rep</source>. (<year>2024</year>) <volume>51</volume>:<fpage>674</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11033-024-09628-w</pub-id>, PMID: <pub-id pub-id-type="pmid">38787497</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Therapeutic effects of human pluripotent stem cell-derived mesenchymal stem cells on a murine model of acute type-2-dominated airway inflammation</article-title>. <source>Stem Cell Rev Rep</source>. (<year>2022</year>) <volume>18</volume>:<page-range>2939&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12015-022-10389-x</pub-id>, PMID: <pub-id pub-id-type="pmid">35622293</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Li</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>KT</given-names>
</name>
</person-group>. <article-title>Three-dimensional bone structure and bone mineral density evaluations of autogenous bone graft after sinus augmentation: A microcomputed tomography analysis</article-title>. <source>Clin Oral Implants Res</source>. (<year>2012</year>) <volume>23</volume>:<page-range>1098&#x2013;103</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0501.2011.02273.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22092756</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname> <given-names>PJ</given-names>
</name>
</person-group>. <article-title>Macrophage polarization</article-title>. <source>Annu Rev Physiol</source>. (<year>2017</year>) <volume>79</volume>:<page-range>541&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034339</pub-id>, PMID: <pub-id pub-id-type="pmid">27813830</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Keefe</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Fibrinolysis as a target to enhance fracture healing</article-title>. <source>N Engl J Med</source>. (<year>2015</year>) <volume>373</volume>:<page-range>1776&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMcibr1510090</pub-id>, PMID: <pub-id pub-id-type="pmid">26510027</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovach</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Dighe</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Lobo</surname> <given-names>PI</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Interactions between mscs and immune cells: implications for bone healing</article-title>. <source>J Immunol Res</source>. (<year>2015</year>) <volume>2015</volume>:<elocation-id>752510</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2015/752510</pub-id>, PMID: <pub-id pub-id-type="pmid">26000315</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ono</surname> <given-names>T</given-names>
</name>
<name>
<surname>Takayanagi</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Osteoimmunology in bone fracture healing</article-title>. <source>Curr Osteoporos Rep</source>. (<year>2017</year>) <volume>15</volume>:<page-range>367&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11914-017-0381-0</pub-id>, PMID: <pub-id pub-id-type="pmid">28647888</pub-id></citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rafiee</surname> <given-names>A</given-names>
</name>
<name>
<surname>Riazi-Rad</surname> <given-names>F</given-names>
</name>
<name>
<surname>Havaskary</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nuri</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Long noncoding rnas: regulation, function and cancer</article-title>. <source>Biotechnol Genet Eng Rev</source>. (<year>2018</year>) <volume>34</volume>:<page-range>153&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/02648725.2018.1471566</pub-id>, PMID: <pub-id pub-id-type="pmid">30071765</pub-id></citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Piao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Lncrna haglros promotes breast cancer evolution through mir-135b-3p/col10a1 axis and exosome-mediated macrophage M2 polarization</article-title>. <source>Cell Death Dis</source>. (<year>2024</year>) <volume>15</volume>:<fpage>633</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-024-07020-x</pub-id>, PMID: <pub-id pub-id-type="pmid">39198393</pub-id></citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The lncrna gas5 upregulates anxa2 to mediate the macrophage inflammatory response during atherosclerosis development</article-title>. <source>Heliyon</source>. (<year>2024</year>) <volume>10</volume>:<elocation-id>e24103</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e24103</pub-id>, PMID: <pub-id pub-id-type="pmid">38293536</pub-id></citation></ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariotti</surname> <given-names>B</given-names>
</name>
<name>
<surname>Servaas</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Rossato</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tamassia</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cassatella</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Cossu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The long non-coding rna NRIR drives ifn-response in monocytes: implication for systemic sclerosis</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>100</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00100</pub-id>, PMID: <pub-id pub-id-type="pmid">30804934</pub-id></citation></ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arumugam</surname> <given-names>P</given-names>
</name>
<name>
<surname>Singla</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lodha</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Identification and characterization of novel infection associated transcripts in macrophages</article-title>. <source>RNA Biol</source>. (<year>2021</year>) <volume>18</volume>:<page-range>604&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15476286.2021.1989217</pub-id>, PMID: <pub-id pub-id-type="pmid">34747322</pub-id></citation></ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzgerald</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>The interferon inducible gene: viperin</article-title>. <source>J Interferon Cytokine Res</source>. (<year>2011</year>) <volume>31</volume>:<page-range>131&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/jir.2010.0127</pub-id>, PMID: <pub-id pub-id-type="pmid">21142818</pub-id></citation></ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Interferon-A Regulates abnormally increased expression of rsad2 in th17 and tfh cells in systemic lupus erythematosus patients</article-title>. <source>Eur J Immunol</source>. (<year>2023</year>) <volume>53</volume>:<elocation-id>e2350420</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.202350420</pub-id>, PMID: <pub-id pub-id-type="pmid">37179450</pub-id></citation></ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>Cresswell</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chin</surname> <given-names>KC</given-names>
</name>
</person-group>. <article-title>Viperin is required for optimal th2 responses and T-cell receptor-mediated activation of nf-kappab and ap-1</article-title>. <source>Blood</source>. (<year>2009</year>) <volume>113</volume>:<page-range>3520&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2008-07-171942</pub-id>, PMID: <pub-id pub-id-type="pmid">19047684</pub-id></citation></ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khantisitthiporn</surname> <given-names>O</given-names>
</name>
<name>
<surname>Shue</surname> <given-names>B</given-names>
</name>
<name>
<surname>Eyre</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Nash</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Turnbull</surname> <given-names>L</given-names>
</name>
<name>
<surname>Whitchurch</surname> <given-names>CB</given-names>
</name>
<etal/>
</person-group>. <article-title>Viperin interacts with pex19 to mediate peroxisomal augmentation of the innate antiviral response</article-title>. <source>Life Sci Alliance</source>. (<year>2021</year>) <volume>4</volume>(<issue>7</issue>):<elocation-id>e20200091</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.26508/lsa.202000915</pub-id>, PMID: <pub-id pub-id-type="pmid">34108265</pub-id></citation></ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Yaneva</surname> <given-names>R</given-names>
</name>
<name>
<surname>Hinson</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Cresswell</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity</article-title>. <source>Science</source>. (<year>2011</year>) <volume>332</volume>:<page-range>1093&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1202007</pub-id>, PMID: <pub-id pub-id-type="pmid">21527675</pub-id></citation></ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparative proteomic analysis of polarized human thp-1 and mouse raw264.7 macrophages</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>700009</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.700009</pub-id>, PMID: <pub-id pub-id-type="pmid">34267761</pub-id></citation></ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Uncovering potential lncrnas and nearby mrnas in systemic lupus erythematosus from the gene expression omnibus dataset</article-title>. <source>Epigenomics</source>. (<year>2019</year>) <volume>11</volume>:<page-range>1795&#x2013;809</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/epi-2019-0145</pub-id>, PMID: <pub-id pub-id-type="pmid">31755746</pub-id></citation></ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Nf-Kb in biology and targeted therapy: new insights and translational implications</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2024</year>) <volume>9</volume>:<fpage>53</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-024-01757-9</pub-id>, PMID: <pub-id pub-id-type="pmid">38433280</pub-id></citation></ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zong</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Interleukin-34-nf-Kb signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization</article-title>. <source>EBioMedicine</source>. (<year>2023</year>) <volume>95</volume>:<elocation-id>104744</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ebiom.2023.104744</pub-id>, PMID: <pub-id pub-id-type="pmid">37556943</pub-id></citation></ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage polarization modulated by nf-Kb in polylactide membranes-treated peritendinous adhesion</article-title>. <source>Small</source>. (<year>2022</year>) <volume>18</volume>:<elocation-id>e2104112</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/smll.202104112</pub-id>, PMID: <pub-id pub-id-type="pmid">34816589</pub-id></citation></ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Gbp5 exacerbates rosacea-like skin inflammation by skewing macrophage polarization towards M1 phenotype through the nf-Kb signalling pathway</article-title>. <source>J Eur Acad Dermatol Venereol</source>. (<year>2023</year>) <volume>37</volume>:<fpage>796</fpage>&#x2013;<lpage>809</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jdv.18725</pub-id>, PMID: <pub-id pub-id-type="pmid">36367676</pub-id></citation></ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamoto</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nakashima</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shinohara</surname> <given-names>M</given-names>
</name>
<name>
<surname>Negishi-Koga</surname> <given-names>T</given-names>
</name>
<name>
<surname>Komatsu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Terashima</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Osteoimmunology: the conceptual framework unifying the immune and skeletal systems</article-title>. <source>Physiol Rev</source>. (<year>2017</year>) <volume>97</volume>:<page-range>1295&#x2013;349</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physrev.00036.2016</pub-id>, PMID: <pub-id pub-id-type="pmid">28814613</pub-id></citation></ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takayanagi</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</article-title>. <source>Nat Rev Immunol</source>. (<year>2007</year>) <volume>7</volume>:<fpage>292</fpage>&#x2013;<lpage>304</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri2062</pub-id>, PMID: <pub-id pub-id-type="pmid">17380158</pub-id></citation></ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>T</given-names>
</name>
<name>
<surname>Crawford</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Osteogenic differentiation of bone marrow mscs by B-tricalcium phosphate stimulating macrophages via bmp2 signalling pathway</article-title>. <source>Biomaterials</source>. (<year>2014</year>) <volume>35</volume>:<page-range>1507&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.11.014</pub-id>, PMID: <pub-id pub-id-type="pmid">24268199</pub-id></citation></ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pajarinen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gibon</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kohno</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Maruyama</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nathan</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Mesenchymal stem cell-macrophage crosstalk and bone healing</article-title>. <source>Biomaterials</source>. (<year>2019</year>) <volume>196</volume>:<page-range>80&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.12.025</pub-id>, PMID: <pub-id pub-id-type="pmid">29329642</pub-id></citation></ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>LY</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>CW</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of skeletal macrophages in fracture repair: A systematic review</article-title>. <source>BioMed Rep</source>. (<year>2020</year>) <volume>13</volume>:<fpage>53</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/br.2020.1360</pub-id>, PMID: <pub-id pub-id-type="pmid">33082950</pub-id></citation></ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mountziaris</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Tzouanas</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Mikos</surname> <given-names>AG</given-names>
</name>
</person-group>. <article-title>Dose effect of tumor necrosis factor-alpha on <italic>in vitro</italic> osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds</article-title>. <source>Biomaterials</source>. (<year>2010</year>) <volume>31</volume>:<page-range>1666&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biomaterials.2009.11.058</pub-id>, PMID: <pub-id pub-id-type="pmid">19963268</pub-id></citation></ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedrich</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aigner</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Therapeutic sirna: state-of-the-art and future perspectives</article-title>. <source>BioDrugs</source>. (<year>2022</year>) <volume>36</volume>:<page-range>549&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40259-022-00549-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35997897</pub-id></citation></ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikam</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Gore</surname> <given-names>KR</given-names>
</name>
</person-group>. <article-title>Journey of sirna: clinical developments and targeted delivery</article-title>. <source>Nucleic Acid Ther</source>. (<year>2018</year>) <volume>28</volume>:<page-range>209&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/nat.2017.0715</pub-id>, PMID: <pub-id pub-id-type="pmid">29584585</pub-id></citation></ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Debacker</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Voutila</surname> <given-names>J</given-names>
</name>
<name>
<surname>Catley</surname> <given-names>M</given-names>
</name>
<name>
<surname>Blakey</surname> <given-names>D</given-names>
</name>
<name>
<surname>Habib</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Delivery of oligonucleotides to the liver with galnac: from research to registered therapeutic drug</article-title>. <source>Mol Ther</source>. (<year>2020</year>) <volume>28</volume>:<page-range>1759&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ymthe.2020.06.015</pub-id>, PMID: <pub-id pub-id-type="pmid">32592692</pub-id></citation></ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akinc</surname> <given-names>A</given-names>
</name>
<name>
<surname>Querbes</surname> <given-names>W</given-names>
</name>
<name>
<surname>De</surname> <given-names>S</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Frank-Kamenetsky</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jayaprakash</surname> <given-names>KN</given-names>
</name>
<etal/>
</person-group>. <article-title>Targeted delivery of rnai therapeutics with endogenous and exogenous ligand-based mechanisms</article-title>. <source>Mol Ther</source>. (<year>2010</year>) <volume>18</volume>:<page-range>1357&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/mt.2010.85</pub-id>, PMID: <pub-id pub-id-type="pmid">20461061</pub-id></citation></ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hur</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Engineered ionizable lipid nanoparticles for targeted delivery of rna therapeutics into different types of cells in the liver</article-title>. <source>Sci Adv</source>. (<year>2021</year>) <volume>7</volume>(<issue>9</issue>):<elocation-id>eabf4398</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciadv.abf4398</pub-id>, PMID: <pub-id pub-id-type="pmid">33637537</pub-id></citation></ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders</article-title>. <source>J Mater Chem B</source>. (<year>2024</year>) <volume>12</volume>:<page-range>4759&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/d3tb02766j</pub-id>, PMID: <pub-id pub-id-type="pmid">38682294</pub-id></citation></ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bumcrot</surname> <given-names>D</given-names>
</name>
<name>
<surname>Manoharan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Koteliansky</surname> <given-names>V</given-names>
</name>
<name>
<surname>Sah</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Rnai therapeutics: A potential new class of pharmaceutical drugs</article-title>. <source>Nat Chem Biol</source>. (<year>2006</year>) <volume>2</volume>:<page-range>711&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nchembio839</pub-id>, PMID: <pub-id pub-id-type="pmid">17108989</pub-id></citation></ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kennington</surname> <given-names>L</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Schelter</surname> <given-names>J</given-names>
</name>
<name>
<surname>Burchard</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Designing sirna that distinguish between genes that differ by a single nucleotide</article-title>. <source>PloS Genet</source>. (<year>2006</year>) <volume>2</volume>:<elocation-id>e140</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.0020140</pub-id>, PMID: <pub-id pub-id-type="pmid">16965178</pub-id></citation></ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Weng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Therapeutic sirna: state of the art</article-title>. <source>Signal Transduct Target Ther</source>. (<year>2020</year>) <volume>5</volume>:<fpage>101</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-020-0207-x</pub-id>, PMID: <pub-id pub-id-type="pmid">32561705</pub-id></citation></ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selvam</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mutisya</surname> <given-names>D</given-names>
</name>
<name>
<surname>Prakash</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ranganna</surname> <given-names>K</given-names>
</name>
<name>
<surname>Thilagavathi</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Therapeutic potential of chemically modified sirna: recent trends</article-title>. <source>Chem Biol Drug Des</source>. (<year>2017</year>) <volume>90</volume>:<page-range>665&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cbdd.12993</pub-id>, PMID: <pub-id pub-id-type="pmid">28378934</pub-id></citation></ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iribe</surname> <given-names>H</given-names>
</name>
<name>
<surname>Miyamoto</surname> <given-names>K</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Leo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Aida</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Chemical modification of the sirna seed region suppresses off-target effects by steric hindrance to base-pairing with targets</article-title>. <source>ACS Omega</source>. (<year>2017</year>) <volume>2</volume>:<page-range>2055&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acsomega.7b00291</pub-id>, PMID: <pub-id pub-id-type="pmid">29450406</pub-id></citation></ref>
</ref-list>
</back>
</article>